<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>278568</rcn>
  <id>101248127</id>
  <acronym>ONCO-DART</acronym>
  <teaser>Oncomatryx Biopharma SL (ONCOMATRYX) is a cutting-edge biotechnology company established in 2010 in Bilbao, Spain, with the mission to pioneer and develop novel precision drugs targeting the tumour microenvironment for indications of high unmet need. We strive to change the...</teaser>
  <objective>Oncomatryx Biopharma SL (ONCOMATRYX) is a cutting-edge biotechnology company established in 2010 in Bilbao, Spain, with the mission to pioneer and develop novel precision drugs targeting the tumour microenvironment for indications of high unmet need. We strive to change the paradigm in the treatment of some of the most aggressive metastatic solid tumors, by neutralizing the immunosuppressive influence of the tumour microenvironment on cancer cells. To achieve this goal, we have developed a comprehensive pipeline of antibody-drug conjugates (ADCs) and human-derived proteins targeting stroma cells in the tumor microenvironment. Our lead candidate, OMTX705, has demonstrated promising safety and efficacy in preclinical models and is currently undergoing Phase I clinical trials for colorectal, pancreatic, lung, and sarcoma cancers. The global market for ADCs is expanding rapidly, with a projected $140 billion opportunity over the next 15 years. ONCOMATRYX aims to leverage this growth through a business strategy focused on out-licensing its assets to pharmaceutical partners for large-scale clinical development and commercialization. The company has already secured a licensing agreement with InxMed for the East Asian market and anticipates a €700M licensing deal for North America, Europe, and Japan upon successful completion of Phase II trials. To advance OMTX705 into Phase Ib and II clinical trials, ONCOMATRYX seeks EIC Accelerator funding, combining a €2.5M grant and a €10M equity investment. This funding will enable parallel execution of Phase Ib studies, accelerate clinical development, and strengthen the company’s market positioning for strategic partnerships. Ultimately, EIC support will be instrumental in achieving key milestones, securing major licensing deals, and driving ONCOMATRYX’s long-term success in transforming cancer treatment.</objective>
  <title>Pioneering antibody-drug conjugates targeting the tumour microenvironment to deliver transformative new therapies in oncology</title>
  <keywords>Antibody-drug conjugates, tumor microenvironment</keywords>
  <totalCost>0</totalCost>
  <ecMaxContribution>2499375.9</ecMaxContribution>
  <startDate>2025-11-01</startDate>
  <endDate>2027-10-31</endDate>
  <ecSignatureDate>2025-10-31</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101248127</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-11-10 12:57:26</sourceUpdateDate>
  <contentCreationDate readOnly="true">2025-11-14 12:36:22</contentCreationDate>
  <contentUpdateDate>2025-11-14 12:36:21</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-14 12:36:22</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>57413</rcn>
        <title>HORIZON-EIC-2025-ACCELERATOR-02</title>
        <identifier>HORIZON-EIC-2025-ACCELERATOR-02</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>57413</rcn>
        <title>HORIZON-EIC-2025-ACCELERATOR-02</title>
        <identifier>HORIZON-EIC-2025-ACCELERATOR-02</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2499375.9" terminated="false" sme="true" netEcContribution="2499375.9" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1992178</rcn>
        <id>952157918</id>
        <vatNumber>ESB95586780</vatNumber>
        <legalName>ONCOMATRYX BIOPHARMA SA</legalName>
        <shortName>ONCOMATRYX BIOPHARMA, S.A</shortName>
        <address>
          <street>PARQUE TECNOLOGICO DE BISCAYA  801</street>
          <city>DERIO</city>
          <postalCode>48160</postalCode>
          <country>ES</country>
          <geolocation>43.2916949,-2.8858821</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Gipuzkoa</name>
              <rcn>242229314</rcn>
              <nutsCode>ES212</nutsCode>
              <parents>
                <region>
                  <name>País Vasco</name>
                  <rcn>242229352</rcn>
                  <nutsCode>ES21</nutsCode>
                  <parents>
                    <region>
                      <name>Noreste</name>
                      <rcn>242231848</rcn>
                      <nutsCode>ES2</nutsCode>
                      <parents>
                        <region>
                          <name>Spain</name>
                          <rcn>242387496</rcn>
                          <nutsCode>ES</nutsCode>
                          <euCode>ES</euCode>
                          <isoCode>ES</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Spain</name>
              <rcn>242387496</rcn>
              <nutsCode>ES</nutsCode>
              <euCode>ES</euCode>
              <isoCode>ES</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>709669</rcn>
        <id>HORIZON_HORIZON-EIC-2025-ACCELERATOR-02-OPEN-01</id>
        <code>HORIZON-EIC-2025-ACCELERATOR-02-OPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Open 2025</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/315/997/1613</code>
        <title>proteins</title>
        <displayCode readOnly="true">/natural sciences/biological sciences/biochemistry/biomolecules/proteins</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category weight="40" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="40" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC-ACC</code>
        <title>HORIZON EIC Accelerator</title>
        <displayCode readOnly="true">/HORIZON EIC Accelerator</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
